Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
Eli Lilly shares rose 4% on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it to extend the
June 08, 2026
SpaceX’s $2 trillion debut met with cheers, jeers and protest
Japanese investors sought more than $6.2 billion worth of SpaceX shares at IPO, sources say
US EPA sends California emissions rules to Congress for potential reversal
Spurs fans still believe they can overcome 3-1 deficit against Knicks to capture 6th NBA title
Dom Perignon, moon pies and fortunes flow as Wall Street feted SpaceX's historic IPO
Blake Lively can recover legal fees from Justin Baldoni, US judge rules